中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2014年
21期
38-40
,共3页
范倩%张秀静%邱明峰%李秀珍%鲁卫星
範倩%張秀靜%邱明峰%李秀珍%魯衛星
범천%장수정%구명봉%리수진%로위성
高血压%肝火亢盛证%潜降颗粒%动态血压监测
高血壓%肝火亢盛證%潛降顆粒%動態血壓鑑測
고혈압%간화항성증%잠강과립%동태혈압감측
Hypertension%Hyperactivityof liverYang,Qianjianggranules,Ambulatory blood pressure monitoring(ABPM)
目的:观察潜降颗粒治疗新发高血压肝火亢盛证患者的临床疗效。方法:选择60例新发高血压辨证为肝火亢盛患者随机分为两组,对照组(20例)采用苯磺酸氨氯地平(压氏达)降压治疗,潜降颗粒组(40例)在采用苯磺酸氨氯地平(压氏达)治疗的基础上加用潜降颗粒治疗,疗程为4周。比较治疗前后两组患者的中医证候积分、降压疗效以及动态血压监测的结果。结果:与对照组相比,潜降颗粒组在中医证候积分、降压疗效以及动态血压监测指标等多方面改善存在统计学差异,P<0.05。结论:潜降颗粒联合西药治疗新发高血压肝火亢盛证患者,能够明显改善患者的血压水平和临床症状,提高临床疗效。
目的:觀察潛降顆粒治療新髮高血壓肝火亢盛證患者的臨床療效。方法:選擇60例新髮高血壓辨證為肝火亢盛患者隨機分為兩組,對照組(20例)採用苯磺痠氨氯地平(壓氏達)降壓治療,潛降顆粒組(40例)在採用苯磺痠氨氯地平(壓氏達)治療的基礎上加用潛降顆粒治療,療程為4週。比較治療前後兩組患者的中醫證候積分、降壓療效以及動態血壓鑑測的結果。結果:與對照組相比,潛降顆粒組在中醫證候積分、降壓療效以及動態血壓鑑測指標等多方麵改善存在統計學差異,P<0.05。結論:潛降顆粒聯閤西藥治療新髮高血壓肝火亢盛證患者,能夠明顯改善患者的血壓水平和臨床癥狀,提高臨床療效。
목적:관찰잠강과립치료신발고혈압간화항성증환자적림상료효。방법:선택60례신발고혈압변증위간화항성환자수궤분위량조,대조조(20례)채용분광산안록지평(압씨체)강압치료,잠강과립조(40례)재채용분광산안록지평(압씨체)치료적기출상가용잠강과립치료,료정위4주。비교치료전후량조환자적중의증후적분、강압료효이급동태혈압감측적결과。결과:여대조조상비,잠강과립조재중의증후적분、강압료효이급동태혈압감측지표등다방면개선존재통계학차이,P<0.05。결론:잠강과립연합서약치료신발고혈압간화항성증환자,능구명현개선환자적혈압수평화림상증상,제고림상료효。
Toobserve the clinical effects of Qianjiang granules in the treatment ofhyperactivityof liverYang in hypertension.Methods:Sixty patients withhyperactivityof liverYang in hypertension wereselected andrandomly divided into two groups, the control group (20 cases) and theQianjiang granules group(40 cases).Patients in the control groupwere treated withamlodipine besylate, while patients in the Qianjiang granules groupwere treated with Qianjiang granules on the basis ofamlodipine besylate,4 weeks as a course.TCM syndrome scores, antihypertensive efficacy and ambulatory blood pressure monitoring were compared after treatment. Results:Compared with the control group, the Qianjiang granules group had statistical differences on TCM Syndromescores,indexes of ambulatory blood pressure monitoring(ABPM),P<0.05.Conclusion:Qianjiang granules combined with western medicinecan improve the clinical effects in the treatment ofhyperactivityof liverYang in hypertensionand significantly improve the efficacy in hypertension patients.